Parametric Portfolio Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$17.3M Sell
224,642
-11,496
-5% -$886K 0.01% 1045
2021
Q4
$20.9M Buy
236,138
+16,189
+7% +$1.43M 0.01% 930
2021
Q3
$17M Buy
219,949
+6,345
+3% +$490K 0.01% 1018
2021
Q2
$17.8M Buy
213,604
+3,347
+2% +$279K 0.01% 1020
2021
Q1
$15.9M Sell
210,257
-12,256
-6% -$925K 0.01% 1314
2020
Q4
$19.5M Buy
222,513
+12,032
+6% +$1.06M 0.01% 1068
2020
Q3
$16M Sell
210,481
-76,372
-27% -$5.81M 0.01% 1045
2020
Q2
$35.4M Buy
286,853
+62,816
+28% +$7.75M 0.03% 565
2020
Q1
$18.9M Buy
224,037
+15,173
+7% +$1.28M 0.02% 815
2019
Q4
$17.7M Buy
208,864
+28,815
+16% +$2.44M 0.01% 1070
2019
Q3
$12.1M Sell
180,049
-44,211
-20% -$2.98M 0.01% 1299
2019
Q2
$19.2M Sell
224,260
-25,057
-10% -$2.15M 0.02% 957
2019
Q1
$22.1M Sell
249,317
-63,743
-20% -$5.66M 0.02% 831
2018
Q4
$26.7M Buy
313,060
+24,518
+8% +$2.09M 0.03% 632
2018
Q3
$28M Buy
288,542
+45,036
+18% +$4.37M 0.02% 681
2018
Q2
$22.9M Buy
243,506
+42,483
+21% +$4M 0.02% 757
2018
Q1
$16.3M Sell
201,023
-5,491
-3% -$445K 0.02% 956
2017
Q4
$18.4M Buy
206,514
+3,484
+2% +$311K 0.02% 855
2017
Q3
$18.9M Sell
203,030
-8,437
-4% -$785K 0.02% 770
2017
Q2
$19.2M Sell
211,467
-2,981
-1% -$271K 0.02% 691
2017
Q1
$18.8M Buy
214,448
+45,955
+27% +$4.03M 0.03% 657
2016
Q4
$14M Buy
168,493
+7,601
+5% +$630K 0.02% 808
2016
Q3
$14.9M Sell
160,892
-7,163
-4% -$663K 0.02% 698
2016
Q2
$13.1M Buy
168,055
+12,707
+8% +$989K 0.02% 752
2016
Q1
$12.8M Buy
155,348
+13,408
+9% +$1.11M 0.02% 769
2015
Q4
$14.9M Sell
141,940
-5,704
-4% -$598K 0.03% 638
2015
Q3
$15.6M Buy
147,644
+2,213
+2% +$233K 0.03% 574
2015
Q2
$19.9M Sell
145,431
-24,362
-14% -$3.33M 0.04% 483
2015
Q1
$21.2M Buy
169,793
+4,843
+3% +$604K 0.04% 452
2014
Q4
$14.9M Buy
164,950
+623
+0.4% +$56.3K 0.03% 577
2014
Q3
$11.9M Buy
164,327
+3,954
+2% +$285K 0.03% 663
2014
Q2
$9.98M Sell
160,373
-11,939
-7% -$743K 0.02% 755
2014
Q1
$11.8M Buy
172,312
+8,693
+5% +$593K 0.03% 640
2013
Q4
$11.5M Sell
163,619
-10,360
-6% -$729K 0.03% 642
2013
Q3
$12.6M Buy
173,979
+419
+0.2% +$30.2K 0.03% 561
2013
Q2
$9.67M Buy
+173,560
New +$9.67M 0.03% 641